Page results
-
This leaflet explains what strong opioid patches are, and how they are used for pain relief at UCLH.
-
This page explains how PIFU will work for you once you have finished your treatment for lymphoma.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
This page explains what vaginal dilation therapy is and includes a step-by-step guide to how it should be performed. If you have any questions, please talk to your healthcare team.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
Information supporting adults affected by cancer and blood conditions being treated at UCLH.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG and topotecan (MATIN) treatment.
-
The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to a part of the brain. This page breaks down the side effects your child may experience during and after treatment, and how best to cope with them.
File results
-
FOI/2024/0573 - Treatment for haemophilia A and B/ von Willebrand patients
-
FOI/2024/0575 - Replacement or purchase of patient trolleys in 2024/25
-
FOI/2022/0780 - Hereditary Angioedema (HAE) service
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments
-
FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2024/0584 - Immunology Hidradenitis Suppurativa (HS) treatments
-
FOI/2024/0583 - National inpatient survey improvements/ night-time noise levels/ ward lighting/ mealtime support
-
FOI/2024/0570 - Pathway for genetic/ genomic testing for MND